top of page
Executive Spotlights

Michael Rossi has been named the new CEO of Y-mAbs Therapeutics

New York, NY, October 18, 2023 (Globe Newswire) -- Y-mAbs Therapeutics, Inc. (Nasdaq: YMAB) has named Michael Rossi as President and CEO, effective November 6, 2023. Rossi will also join the company's Board of Directors. Y-mAbs focuses on developing and commercializing antibody-based therapeutic products for cancer treatment.

Read full article here.

Recent Posts

See All

Rahway, NJ & Cambridge, MA, November 21, 2023 (Business Wire) -- Merck (NYSE: MRK), also known as MSD outside of the United States and Canada, and Caraway Therapeutics, Inc. declare a definitive agr

Life Science Headlines
bottom of page